La conférence internationale organisée dans le cadre du projet ANR MEDICI, intitulée “Corporate Interests and Public Health. Knowledge, Expertise, Markets” aura lieu les 9-10-11 décembre 2019 à l’EHESS, au Centre de colloques du Campus Condorcet (métro Front Populaire). Partant de la notion de “conflit d’intérêts”, les membres du projet et des invités y présenteront leurs enquêtes sur la question de l’influence industrielle, et nous accueillerons également des chercheurs internationaux spécialistes de la question de l’influence et des conflits d’intérêts, qui y donneront des conférences invitées, parmi lesquels Sergio Sismondo, Marc Rodwin et Lisa Cosgrove.
- Jill Fisher (UNC-Chapel Hill) “Investigating the Inherent Conflicts of Interest in Commercial Phase I Trials”.
- David Demortain (INRA) “The Pharmaceutical Industry and the Production of Regulatory Knowledge. Exploring the Systemic Determinants of Conflicts of Interests”.
- Melanie Jeske (UCSF) Conflict of Interest’ or Simply ‘Interest’? Shifting Values in Translational Medicine.
- Boris Hauray (Inserm) “Publishing Impure Science. The Politics of Conflict of Interest in Medical Journals”.
- Nathalie Jas (INRA) “Industry Quiet Power. Shaping WHO/FAO Food Additives and Contaminants Expert Committees’ Work in the Post-WWII period”.
- Annie Martin (CNRS) “Conflict of Interest and European Law. The European Medicines Agency’s case”.
- Jérôme Greffion (Université Paris 10) & Hélène Michel (Université de Strasbourg) “Medical Experts at work in a Committee of the French National Authority for Health”.
- Volker Hess (Charité) “Clinical Trials, Evidence-Based Medicine and the Pharmaceutical Industry”.
- Jean-Paul Gaudillière (Inserm/EHESS) “Scientific Marketing and Conflict of Interest. Lessons from the Hormone Replacement Therapies Crisis”.
- Etienne Nouguez (CNRS) “Fighting over Generic Medicines. Struggles between Pharmaceutical Companies to Influence the Prescriptions of French Doctors and Pharmacists”.
- Henri Boullier (Inserm) & Jérôme Greffion (Université Paris 10) “The Materiality of Transparency. Constructing a Database on Physicians Funding”.
- Christian Bonah & Solène Lellinger (Université de Strasbourg) “‘This Corporation has ‘Anaesthetized’ the Actors in the Drug Chain’. Influence Peddling and the Normality of Conflict of Interest in the Benfluorex Case”.
- Giovanni Prete (Université Paris 13), François Dedieu (INRA) & Jean-Noël Jouzel (CNRS) “Denouncing Pesticides in France: Conflict of Interest as a Protest Repertoire”.
- Sébastien Dalgalarrondo (CNRS) “Patient Mobilizations and Industry Influence: from AIDS to Alzheimer”.